Drug
COLD-fX clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 1
Afexa Life Sciences Inc (2) · CV Technologies (2) · Capital Health, Canada (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses COLD-fX is read from its arms, and is right about nine times in ten.
Testing it · 5
- Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic LeukemiaWithdrawnPhase 1Afexa Life Sciences IncNCT01456182Written as AFX-2
- Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling SeniorsCompletedPhase 3Capital Health, CanadaNCT00240461Written as COLD-fX
- A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic RhinitisCompletedPhase 2Afexa Life Sciences IncNCT00726401Written as COLD-fX
- Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy AdultsCompletedPhase 3CV TechnologiesNCT00259831Written as CVT-E002 (Cold-FX); a natural health product
- Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy AdultsCompletedPhase 2CV TechnologiesNCT00435968Written as CVT E002 (Cold-fX)